Document is current

Any future updates will be listed below

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis

Crossref DOI link: https://doi.org/10.1007/s12325-020-01476-x

Published Online: 2020-09-01

Published Print: 2020-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark